We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
125 hedge funds and large institutions have $360M invested in Anika Therapeutics in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 49 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
928% more call options, than puts
Call options by funds: $2.47M | Put options by funds: $240K
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
7% more capital invested
Capital invested by funds: $335M → $360M (+$24.4M)
2% more funds holding
Funds holding: 122 → 125 (+3)
6.74% less ownership
Funds ownership: 96.45% → 89.71% (-6.7%)
24% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 49
Holders
125
Holders Change
+3
Holders Change %
+2.46%
% of All Funds
2.01%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
37
Reduced
49
Closed
13
Calls
$2.47M
Puts
$240K
Net Calls
+$2.23M
Net Calls Change
+$684K
Top Buyers
| 1 |
BFM
Boothbay Fund Management
New York
|
+$5.62M |
| 2 |
Millennium Management
New York
|
+$3.42M |
| 3 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$2.06M |
| 4 |
BlackRock
New York
|
+$1.92M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.86M |
